IC
TEVA icon

IKOS CIF’s Teva Pharmaceuticals TEVA Stock Holding History

IKOS CIF’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$766K Buy
+16,171
New +$844K 4.6% 3

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

IKOS CIF's TEVA Position: Q3 2016 in Review

IKOS CIF opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2016: 16,171 shares worth $766K. The stake represents 4.6% of the portfolio and ranks #3 among its holdings.

795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • IKOS CIF held 16,171 shares of Teva Pharmaceuticals worth $766K as of Q3 2016.
  • Teva Pharmaceuticals was a new IKOS CIF position in Q3 2016.
  • Teva Pharmaceuticals made up 4.6% of IKOS CIF's portfolio in Q3 2016, its #3 holding.
  • 795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on IKOS CIF's 13F filing for Q3 2016, filed 10 Nov 2016.